Lennar Corp. is down more than 3% in New York after Wedbush downgraded its opinion from 'neutral' to 'underperform' on the stock, as well as on four other US homebuilding names (including DR Horton), in a sector note. The price target is nonetheless maintained at $144.

The broker leaves its EPS estimates unchanged for the five stocks in question, but believes they could experience a normal seasonal decline for this summer, particularly after the seasonal trading window closes in April-May.

Copyright (c) 2024 CercleFinance.com. All rights reserved.